An alarming retraction rate for scientific publications on Coronavirus Disease 2019 (COVID-19).


Journal

Accountability in research
ISSN: 1545-5815
Titre abrégé: Account Res
Pays: United States
ID NLM: 9100813

Informations de publication

Date de publication:
01 2021
Historique:
pubmed: 24 6 2020
medline: 5 1 2021
entrez: 24 6 2020
Statut: ppublish

Résumé

The ongoing Coronavirus Disease 2019 (COVID-19) global pandemic has triggered a flurry of associated research publications, numbering to ~137 papers a day since February 2020. This rate of publication appears to be exceptionally high, when compared to research papers published on other similar topics. Searches of COVID-19-associated publications on PubMed and Retraction Watch Database indicate that the retraction record appearance rate for COVID-19-related research is also exceptionally high compared to other related research topics in viral epidemics/pandemics and surpasses the basal level of about 4 in 10,000 papers. This finding serves as a reminder and caution against any lapses in the standard of work, peer review, and publication of COVID-19-related research.

Identifiants

pubmed: 32573274
doi: 10.1080/08989621.2020.1782203
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

47-53

Commentaires et corrections

Type : CommentIn

Auteurs

Nicole Shu Ling Yeo-Teh (NSL)

Research Compliance and Integrity Office, National University of Singapore , Singapore, Republic of Singapore.

Bor Luen Tang (BL)

Research Compliance and Integrity Office, National University of Singapore , Singapore, Republic of Singapore.
NUS Graduate School for Integrative Sciences and Engineering, National University of Singapore , Singapore, Republic of Singapore.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH